The new guidelines, published in the Journal of the American Academy of Dermatology (JAAD), will guide dermatologists in deciding the best possible prevention and treatment options for pediatric ...

VTAMA was the only steroid-free topical AAD found supported by high certainty of evidence across all severities in children 2 years and older with AD.

There's very little parents can do to prevent their kids from developing eczema, according to new guidelines from the ...

The significant burden imposed by AD on patients and the health care system includes increases in hospitalizations, health care costs, loss of work productivity, and disability. 9-14 This impact is ...